HB907: Sickle cell anemia; treatment.


VIRGINIA ACTS OF ASSEMBLY -- CHAPTER
An Act to amend and reenact § 32.1-68 of the Code of Virginia, relating to Department of Health; sickle cell anemia; adult and pediatric comprehensive sickle cell clinic network.
[H 907]
Approved

 

Be it enacted by the General Assembly of Virginia:

1. That § 32.1-68 of the Code of Virginia is amended and reenacted as follows:

§ 32.1-68. Commissioner to establish screening and treatment program; review by Board; program to include education and post-screening counseling; laboratory tests.

A. The Commissioner, in cooperation with local health directors, shall establish a voluntary program for the screening of individuals adults and children for the disease of sickle cell anemia or the sickle cell trait and for such other genetically related diseases and genetic traits and inborn errors of metabolism as the Board may deem necessary.

B. The Board shall review the program from time to time to determine the appropriate age and the method of screening for such conditions or traits in the light of technological changes.

C. The screening program shall include provisions for education concerning the nature and treatment of sickle cell anemia, other genetically related diseases and inborn errors of metabolism and a post-screening counseling program for the treatment of any person determined to have such a condition.

D. The program may include the provision of laboratory testing.

E. The Board shall adopt regulations to implement an adult and pediatric comprehensive sickle cell clinic network.


HOUSE BILL NO. 907
AMENDMENT IN THE NATURE OF A SUBSTITUTE
(Proposed by the House Committee on Health, Welfare and Institutions
on January 28, 2020)
(Patron Prior to Substitute--Delegate Hayes)
A BILL to amend and reenact § 32.1-68 of the Code of Virginia, relating to Department of Health; sickle cell anemia; adult and pediatric comprehensive sickle cell clinic network.

Be it enacted by the General Assembly of Virginia:

1. That § 32.1-68 of the Code of Virginia is amended and reenacted as follows:

§ 32.1-68. Commissioner to establish screening and treatment program; review by Board; program to include education and post-screening counseling; laboratory tests.

A. The Commissioner, in cooperation with local health directors, shall establish a voluntary program for the screening of individuals adults and children for the disease of sickle cell anemia or the sickle cell trait and for such other genetically related diseases and genetic traits and inborn errors of metabolism as the Board may deem necessary.

B. The Board shall review the program from time to time to determine the appropriate age and the method of screening for such conditions or traits in the light of technological changes.

C. The screening program shall include provisions for education concerning the nature and treatment of sickle cell anemia, other genetically related diseases and inborn errors of metabolism and a post-screening counseling program for the treatment of any person determined to have such a condition.

D. The program may include the provision of laboratory testing.

E. The Board shall adopt regulations to implement an adult and pediatric comprehensive sickle cell clinic network.

HOUSE BILL NO. 907

Offered January 8, 2020
Prefiled January 7, 2020
A BILL to amend and reenact § 32.1-68 of the Code of Virginia, relating to Department of Health; sickle cell anemia; treatment.
Patron-- Hayes

Committee Referral Pending

Be it enacted by the General Assembly of Virginia:

1. That § 32.1-68 of the Code of Virginia is amended and reenacted as follows:

§ 32.1-68. Commissioner to establish screening and treatment program; review by Board; program to include education and post-screening counseling; laboratory tests.

A. The Commissioner, in cooperation with local health directors and health care providers, shall establish a voluntary program for the screening of individuals for and the treatment of individuals identified as having the disease of sickle cell anemia or the sickle cell trait and for such other genetically related diseases and genetic traits and inborn errors of metabolism as the Board may deem necessary.

B. The Board shall review the program from time to time to determine the appropriate age and the method of screening and treatment for such conditions or traits in the light of technological changes.

C. The screening program shall include provisions for education concerning the nature and treatment of sickle cell anemia, other genetically related diseases and inborn errors of metabolism and a post-screening counseling program for the treatment of any person determined to have such a condition.

D. The program may include the provision of laboratory testing.

E. The Board shall adopt regulations to implement the provisions of this section.